source
- Myriad Genetics sells prenatal testing business to Labcorp for $210 millionMyriad Genetics announced it will divest its Prenatal Health testing division to Labcorp, receiving $210 million in cash. The transaction includes Myriad's Prequel, Foresight, SneakPeek and FirstG…
- Endpoints AI Day highlights agents, AI slop and biosecurity gaps in pharmaEndpoints News held its third AI Day, an event dedicated to exploring how artificial intelligence can be applied across drug discovery and development. Speakers, including Nathan Frey of Anthropic…